Active Surveillance in China Evaluates Post-Marketing Safety of Quadrivalent Subunit Influenza Vaccine
A Phase IV prospective active surveillance study in Jiangsu, China, found that an independently developed quadrivalent subunit influenza vaccine demonstrated ...




